All stock lists
Varonis Systems Inc (NASDAQ:VRNS)
US · Delayed Price · Currency is USD
Also listed: 0VOU.LTechnology · Software - Infrastructure
48.73-0.07 (-0.14%)
Market cap
$5.60B
Insider Score
Health Score
Analyst consensus
Listed since
Feb 28, 2014
Website
Insider Score
––Not scored
VRNS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From VRNS’s reported statements · Q3 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $716.0M
- Net income
- -$153.1M
- Net margin
- -21.4%
Leverage8 / 20
A manageable debt load.
- Total debt
- $514.3M
- Cash
- $271.0M
- Debt / equity
- 1.19
Liquidity13 / 20
Covers near-term obligations, without much room.
- Current assets
- $920.4M
- Current liabilities
- $627.3M
- Current ratio
- 1.47
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $133.0M
- Free cash flow
- $117.2M
- FCF margin
- 16.4%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 115.0M
- Share growth (1y)
- 0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
VRNS Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 189.46 M | 180.02 M | 173.13 M | 173.37 M | 161.58 M | 152.16 M |
| Revenue Growth (YoY) | 17.26 % | 18.31 % | 26.90 % | 9.37 % | 9.12 % | 16.74 % |
| Cost of Revenue | 46.89 M | 44.51 M | 41.57 M | 36.56 M | 35.15 M | 31.25 M |
| Gross Profit | 142.57 M | 135.51 M | 131.56 M | 136.81 M | 126.43 M | 120.91 M |
| SG&A Expense | 111.62 M | 102.80 M | 105.20 M | 102.45 M | 99.63 M | 101.22 M |
| R&D Expense | 78.67 M | 73.34 M | 69.76 M | 64.62 M | 62.74 M | 56.25 M |
| Operating Expenses | 190.28 M | 176.14 M | 176.04 M | 167.07 M | 162.36 M | 157.47 M |
| Operating Income | -47.71 M | -40.63 M | -44.48 M | -30.26 M | -35.93 M | -36.55 M |
| Pretax Income | -38.53 M | -41.39 M | -40.03 M | -24.79 M | -28.13 M | -31.59 M |
| Tax Provision | 3.12 M | -5.42 M | -3.18 M | 2.98 M | 1.81 M | 4.24 M |
| Net Income | -41.65 M | -46.81 M | -36.85 M | -27.77 M | -29.94 M | -35.82 M |
| EPS (Basic) | -0.36 | -0.41 | -0.32 | -0.23 | -0.26 | -0.32 |
| EPS (Diluted) | -0.36 | -0.41 | -0.32 | -0.23 | -0.26 | -0.32 |
| Shares Outstanding | 115.00 M | 115.30 M | 115.79 M | 129.17 M | 114.97 M | 112.05 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.